{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:19:49Z","timestamp":1789903189753,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.medmal.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T20:08:10Z","timestamp":1541189290000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France"],"prefix":"10.1016","volume":"49","author":[{"given":"C.","family":"Duployez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lo\u00efez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cattoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vach\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2018.10.007_bib0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.medmal.2014.09.004","article-title":"Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use","volume":"44","author":"Lepeule","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2018.10.007_bib0100","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Infections urinaires, argumentaire. [Accessed on August 8th 2016. Available from: http:\/\/www.infectiologie.com\/UserFiles\/File\/spilf\/recos\/infections-urinaires-spilf-argumentaire.pdf]."},{"key":"10.1016\/j.medmal.2018.10.007_bib0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.10.007_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antinf.2013.04.004","article-title":"T\u00e9mocilline, une alternative aux carbap\u00e9n\u00e8mes pour traiter les infections \u00e0 ent\u00e9robact\u00e9ries r\u00e9sistantes aux C3G\u00a0?","volume":"15","author":"Soubirou","year":"2013","journal-title":"J Anti Infect"},{"key":"10.1016\/j.medmal.2018.10.007_bib0115","series-title":"Comit\u00e9 de l\u2019antibiogramme de la Socit\u00e9t\u00e9 fran\u00e7aise de microbiologie V2_030915","year":"2015"},{"key":"10.1016\/j.medmal.2018.10.007_bib0120","series-title":"Standardized disc susceptibility testing method \u2013 Version-12-Apr-2013","author":"British Society for Antimicrobial Chemotherapy","year":"2013"},{"key":"10.1016\/j.medmal.2018.10.007_bib0125","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3346\/jkms.2014.29.8.1178","article-title":"Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea","volume":"29","author":"Seo","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.medmal.2018.10.007_bib0130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cmi.2015.05.022","article-title":"Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin","volume":"21","author":"Giske","year":"2015","journal-title":"Clin Microbiol Infect Off"},{"key":"10.1016\/j.medmal.2018.10.007_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2018.10.007_bib0140","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jac\/dkl043","article-title":"Activity of temocillin against prevalent ESBL \u2013 and AmpC-producing Enterobacteriaceae from south-east England","volume":"57","author":"Livermore","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.10.007_bib0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jac\/dkl046","article-title":"In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli","volume":"57","author":"Rodriguez-Villalobos","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.10.007_bib0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10096-011-1183-4","article-title":"In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli","volume":"30","author":"T\u00e4rnberg","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2018.10.007_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/23744235.2015.1087648","article-title":"The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010\u20132011","volume":"48","author":"Zykov","year":"2016","journal-title":"Infect Dis Lond Engl"},{"key":"10.1016\/j.medmal.2018.10.007_bib0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02148656","article-title":"Interpretive criteria for temocillin disk diffusion susceptibility testing","volume":"4","author":"Fuchs","year":"1985","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.medmal.2018.10.007_bib0165","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.10.007_bib0170","series-title":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit -\u00a0NEGABAN 1g poudre pour solution injectable","year":"2014"},{"key":"10.1016\/j.medmal.2018.10.007_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkm179","article-title":"Temocillin susceptibility by BSAC methodology","volume":"60","author":"Andrews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.10.007_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2295333714Y.0000000066","article-title":"Establishing quality control ranges for temocillin following CLSI-M23-A3 guideline","volume":"70","author":"Maurissen","year":"2015","journal-title":"Acta Clin Belg"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17308995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17308995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:16:54Z","timestamp":1759972614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17308995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0399077X17308995"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.10.007","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}